Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 95.42
1.71 %
$ 6.53 B
Market Cap
21.89
P/E
Price Target
Average
59.30%
Revenue Forecast
Estimate
24.74%
EBIT
Estimate
--23.36%
Net Income
Estimate
34.36%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Lantheus Holdings, Inc.
Wall Street analysts predict an average 1-year price target for LNTH of $152 , with forecasts ranging from
a
low of
$125 to a high of $175 .
LNTH Lowest Price Target
Wall Street Target
125 USD
31.00%
LNTH Average Price Target
Wall Street Target
152 USD
59.30%
LNTH Highest Price Target
Wall Street Target
175 USD
83.40%
REVENUE FORECAST
Revenue Forecast Chart LNTH
EBIT FORECAST
EBIT Forecast Chart LNTH
NET INCOME FORECAST
Net Income Chart LNTH